Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

India's Dr Reddy's Laboratories up on deal to divest non-core brands

** Shares of Dr Reddy's Laboratories  REDY.NS  rise nearly
2% to 4,463.15 rupees, highest in over two weeks
    ** Drugmaker signs deal to divest co's non-core brands in
dermatory segments to Eris Lifesciences  ERIS.NS  
    ** Eris Lifesciences to buy these brands' trademark for 2.75
bln rupees ($33.35 million); ERIS stock up nearly 1%
    ** The divested portfolio had annual sales of 600 mln rupees
in the 12-months ending Dec 2022, according to IQVIA data
    ** REDY among top gainers in pharma sector  .NIPHARM ; the
benchmark pharma index is up 0.05%, as of 12:09 p.m. IST


($1 = 82.4660 Indian rupees)
    

 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; +91 9769003463))

Recent news on Eris Lifesciences

See all news